Public Sector Pension Investment Board (PSP Investments)’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.8M Buy
92,286
+2,924
+3% +$778K 0.07% 193
2025
Q4
$22M Sell
89,362
-11,069
-11% -$2.33M 0.07% 191
2025
Q3
$17.7M Buy
100,431
+13,743
+16% +$2.06M 0.07% 241
2025
Q2
$11.9M Buy
86,688
+6,424
+8% +$944K 0.05% 309
2025
Q1
$14.5M Buy
80,264
+17,254
+27% +$2.9M 0.06% 237
2024
Q4
$9.87M Buy
63,010
+9,354
+17% +$1.66M 0.04% 336
2024
Q3
$9.77M Sell
53,656
-1,000
-2% -$193K 0.05% 221
2024
Q2
$10M Buy
+54,656
New +$9.18M 0.06% 193

Other funds holding KRYS

Public Sector Pension Investment Board (PSP Investments)'s KRYS Position: Q1 2026 in Review

Public Sector Pension Investment Board (PSP Investments) increased its Krystal Biotech (KRYS) stake by 3.3% in Q1 2026, buying an estimated $778K and bringing the position to 92,286 shares worth $23.8M. The position accounts for 0.07% of the portfolio, ranked #193.

Public Sector Pension Investment Board (PSP Investments) first reported a position in KRYS in Q2 2024 and has held it in 8 quarters since. 367 funds tracked by Wall St. Rank hold KRYS as of Q1 2026.

  • Public Sector Pension Investment Board (PSP Investments) held 92,286 shares of Krystal Biotech worth $23.8M as of Q1 2026.
  • Public Sector Pension Investment Board (PSP Investments) bought 2,924 Krystal Biotech shares in Q1 2026, an estimated $778K.
  • Krystal Biotech made up 0.07% of Public Sector Pension Investment Board (PSP Investments)'s portfolio in Q1 2026, its #193 holding.
  • Public Sector Pension Investment Board (PSP Investments) first reported a position in Krystal Biotech in Q2 2024 and has held it in 8 quarters since.
  • 367 funds tracked by Wall St. Rank held Krystal Biotech as of Q1 2026.

Based on Public Sector Pension Investment Board (PSP Investments)'s 13F filing for Q1 2026, filed 13 May 2026.